|
MechanismGlutamates modulators |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhaseDiscontinued |
First Approval Ctry. / Loc.- |
First Approval Date- |
|
MechanismmGluR5 antagonists |
Active Org.- |
|
Active Indication- |
|
Drug Highest PhasePending |
First Approval Ctry. / Loc.- |
First Approval Date- |
100 Clinical Results associated with Neuropharm Group Plc
0 Patents (Medical) associated with Neuropharm Group Plc
100 Deals associated with Neuropharm Group Plc
100 Translational Medicine associated with Neuropharm Group Plc